Utilities / Utilities - RenewableUpdated 2026-05-10 22:07 UTC

IST/BIOEN stock hub

IST/BIOEN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IST/BIOENis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

10.2B

Istanbul Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

IST/BIOEN

In the news

Latest news · IST/BIOEN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 8.8P50 10.4P75 21.3

Trailing P/En/a

P25 14.5P50 23.1P75 27.5

ROE-38.1

P25 -8.7P50 1.2P75 6

ROIC-4

P25 -0.6P50 1.6P75 3.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IST/BIOEN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

177

Groups with data

Currency

TRY

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Turkey
Country code	TR
Employees	824
Employees Change	107%
Employees Change Percent	14.92
Enterprise value	TRY 15.3B
Exchange	Istanbul Stock Exchange
Financial currency	TRY
First seen	2026-05-10
Industry	Utilities - Renewable
Isin	TREBION00012
Last refreshed	2026-05-10
Market cap	TRY 10.2B
Price	TRY 20.42
Price currency	TRY
Rev Per Employee	3,571,485.42x
Sector	Utilities
Sic	4911
Symbol	ist/BIOEN
Website	https://www.biotrendenerji.com.tr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-13.54%
EV Earnings	-11.1x
EV/EBITDA	46.26x
EV/FCF	99.83x
EV/Sales	5.21x
FCF yield	1.51%
P/B ratio	3.66x
P/S ratio	3.47x
PE Ratio5 Y	101.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-19.11%
EBITDA Margin	7.26%
FCF margin	5.22%
Gross margin	3.39%
Gross Profit	TRY 99.8M
Net Income	TRY -1.4B
Pretax Margin	-26.23%
Profit Margin	-46.97%
Profit Per Employee	TRY -1.7M
ROA	-3.33
Roa5y	1.06
ROCE	-7.88
ROE	-38.07
Roe5y	8.12
ROIC	-3.98

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	8.91%
Cagr3y	13.51%
Cagr5y	30.45%
OCF Growth3 Y	-12.49%
OCF Growth5 Y	69.1%
Revenue Growth	-17.33x
Revenue Growth Q	-16.73x
Revenue Growth3 Y	7.98x
Revenue Growth5 Y	64.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TRY 0.28
Assets	TRY 9.7B
Cash	TRY 77.6M
Current Assets	TRY 795.5M
Current Liabilities	TRY 2.5B
Debt	TRY 5.2B
Debt EBITDA	TRY 15.3
Debt Equity	TRY 1.87
Debt FCF	TRY 33.9
Equity	TRY 2.8B
Interest Coverage	-0.97
Liabilities	TRY 6.9B
Long Term Assets	TRY 8.9B
Long Term Liabilities	TRY 4.3B
Net Cash	TRY -5.1B
Net Cash By Market Cap	TRY -50.27
Net Debt EBITDA	TRY 24.04
Net Debt Equity	TRY 1.84
Net Debt FCF	TRY 33.4
Tangible Book Value	TRY 2.4B
Tangible Book Value Per Share	TRY 4.77
WACC	6.58

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.31
Inventory Turnover	8.78
Net Working Capital	TRY -181.3M
Quick ratio	0.11
Working Capital	TRY -1.8B
Working Capital Turnover	TRY -2.23

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	8.91%
200-day SMA	20.33
3Y total return	46.28%
50-day SMA	17.84
50-day SMA vs 200-day SMA	50under200
5Y total return	277.73%
All Time High	27.96
All Time High Change	-26.97%
All Time High Date	2025-10-01
All Time Low	4.68
All Time Low Change	336.32%
All Time Low Date	2022-02-24
ATR	1.1
Beta	0.22
Beta1y	0.15
Beta2y	-0.16
Ch YTD	22.28
High	21.74
High52	27.96
High52 Date	2025-10-01
High52ch	-26.97%
Low	20.42
Low52	14.67
Low52 Date	2026-03-02
Low52ch	39.2%
Ma50ch	14.44%
Price vs 200-day SMA	0.46%
RSI	58.94
RSI Monthly	52.99
RSI Weekly	54.97
Sharpe ratio	0.17x
Sortino ratio	0.43
Tr YTD	22.28
Tr1m	23.83%
Tr1w	0.79%
Tr3m	6.19%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TRY -562.3M
Operating margin	-19.11

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	197,934,886%
Net Borrowing	137,305,858
Shares Institutions	18.35%
Shares Out	500,000,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TRY 153.7M
Average Volume	12,968,487.95x
Bv Per Share	5.58
CAPEX	TRY -578.8M
Ch1m	23.83
Ch1w	0.79
Ch1y	8.91
Ch3m	6.19
Ch3y	46.28
Ch5y	277.7
Ch6m	-5.46
Change	-5.46%
Change From Open	-5.55
Close	21.6
Days Gap	0.09
Dollar Volume	210,261,268.6
Earnings Date	2026-05-15
EBIT	TRY -562.3M
EBITDA	TRY 213.5M
EPS	TRY -2.76
F Score	2
FCF	TRY 153.7M
FCF EV Yield	1x
FCF Per Share	TRY 0.31
Financing CF	-343,321,114
Fiscal Year End	December
Founded	2,017
Income Tax	TRY 610.3M
Investing CF	-439,110,364
Is Primary Listing	1
Last Earnings Date	2025-11-07
Last Report Date	2025-12-31
Last Split Date	2021-11-24
Last Split Type	Forward
Ma150	19.28
Ma150ch	5.94%
Ma20	19.51
Ma20ch	4.68%
Net CF	-75,894,065
Next Earnings Date	2026-05-15
Open	21.62
P FCF Ratio	66.43
P OCF Ratio	13.94
Position In Range	0
Ppne	7,354,381,635
Price Date	2026-05-08
Price EBITDA	TRY 47.81
Ptbv Ratio	4.28
Relative Volume	0.79x
Revenue	2,942,903,984x
Tax By Revenue	20.74x
Tr6m	-5.46%
Volume	10,296,830

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IST/BIOEN pay a dividend?

Capital-return profile for this ticker.

Performance

IST/BIOEN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IST/BIOEN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+18.3%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

IST/BIOEN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.9

Neutral momentum band

Price vs 200-day MA

+0.5%

50/200-day relationship not available

Beta (5Y)

0.22

Less volatile than the market

Sharpe ratio

0.17

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IST/BIOEN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ist/BIOEN stock rating?

ist/BIOEN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ist/BIOEN analysis?

The full report lives at /stocks/ist/BIOEN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ist/BIOEN?

The latest report frames ist/BIOEN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ist/BIOEN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.